4Oymar K, Aksnes L. Increased levels of urinary leukotriene E4 in children with severe atopic eczema/dermatitis syndrome[J]. Al- lergy, 2005, 60(1): 86-89.
5Hishinuma T, Suzuki N, Aiba S, et aL Increased urinary leukotriene E4 excretion in patients with atopic dermatitis[J]. Br J Dermatol, 2001, 144(1): 19-23.
6Adamek-Guzik T, Guzik TJ, Czerniawska-Mysik G, et al. Uri- nary leukotriene levels are increased during exacerbation of atopic eczema/dermatitis syndrome. Relation to clinical status[J]. Allergy, 2002, 57(8): 732-736.
7Broshtilova V, Ganteheva M. Therapeutic hotline: eysteinyl leukotriene receptor antagonist montelukast in the treatment of atopic dermatitis[J]. Dermatol Ther, 2010, 23(1): 90-93.
8Angelova-Fischer I, Tsankov N. Successful treatment of severe atopic dermatitis with cysteinyl leukotriene receptor antagonist montelukast[J]. Acta Dermatovenerol Alp Panonica Adriat, 2005, 14(3): 115-119.
9Veien NK, Busch-Sorensen M,Stausbol-Gron B. Montelukast treatment of moderate to severe atopic dermatitis in adults: a randomized, double-blind, placebo-controlled trial[J]. J Am Acad Dermatol, 2005, 53(1): 147-149.
2REILLY D M,PARSLEW R,SHARPE G R,et al.Inflammatory mediators in normal,sensitive and diseased skin types[J].Acta Derm Venereol,2000,80:171-174.
3SHIMADA Y,TAKEHARA K,SATO S.Both Th2 and Th1 chemokines(TARC/CCL17.MDC/CCL22 and Mig/CXCL9) are elevated in sera from patients with atopic dermatitis[J].J Dermatol Sci,2004,34:201-208.
4KORO O,FURUTANI K,HIDE M,et al.Chemical mediators in atopic dermatitis:involvement of leukotriene B4 released by a type I allergic reaction in the pathogenesis of atopic dermatitis[J].J Allergy Clin Immunol,1999,103:663-670.
5Reilly DM, Parslew R, Sharpe GR, et al. Inflammatory mediators in normal,sensitive and diseased skin types. Acta Derm Venereol, 2000, 80: 171-174.
6Shimada Y, Takehara K, Sato S. Both Th2 and Thl chemokines (TARC/CCL17, MDC/CCL22, and Mig/CXCL9) are elevated in sera from patients with atopie dermatitis. J Dermatol Sci, 2004, 34: 201-208.
7Sofia BP, Gennady YM, Galina RP, et al.Dietary phospholipids in chronic eczema.Prostaglandins Other Lipid Mediat, 1999,59: 207.
8Triggiani M, Giannanasio G, Balestrieri B, et al. Differential modulation of mediator release from human basophils and mast cells by mizolastine. Clin Exp Allergy, 2004, 34:241-249.
9Oymar K,Aksnes L.Increased levels of urinary leukotriene E4 in children with severe atopic eczema/dermatitis syndrome.Allergy,2005,60:86-89.
10Ikai K.Psoriasis and the arachidonic acid cascade.J Dermatol Sci,1999,21:135-146.
